FDA Inspection 1315888 — LifeServe Blood Center

LifeServe Blood Center — FEI 3011389677

The FDA completed an inspection of LifeServe Blood Center on April 14, 2026 in Sioux City, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 14, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Sioux City, IA (United States)